Literature DB >> 24372982

An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer.

C Kreatsoulas1, S S Anand, S V Subramanian.   

Abstract

OBJECTIVE: Cardiovascular disease (CVD) and cancer are the two leading causes of death in the United States; at the same time, the number of survivors is increasing as therapies continue to improve. The primary objective of this study is to determine the prevalence and characteristics of individuals affected by both CVD and cancer. DESIGN AND
SETTING: We conducted a prevalence study using the 2009 and 2010 national Behavioural Risk Factor Surveillance System population survey. Data from a random sample of individuals (aged 25-99 years) from all states were collected. All participants provided information regarding their CVD and cancer status. Multivariable regression identified associations between participants' characteristics and the prevalence of double disease burden.
RESULTS: Amongst 442,964 study participants, the overall prevalence rates were 11% for CVD and 15% for cancer; 3% of participants reported being survivors of both CVD and cancer. The prevalence of CVD+cancer increased twofold by 65 years of age (odds ratio [OR] 2.4, 95% confidence interval [CI] 2.3-2.5) and doubled again at ≥75 years (OR 4.9, 95% CI 4.6-5.1) and was higher amongst men (OR 1.6, 95% CI 1.6-1.7), multiracial individuals (OR 1.8, 95% CI 1.5-2.0) and those without a high school diploma (OR 1.3, 95% CI 1.2-1.4). Amongst individuals with CVD, 25% also reported having cancer, whilst 19% of all cancer survivors reported having CVD.
CONCLUSIONS: The prevalence of the double burden of disease increased with age; this is particularly important as the 'baby boomers' reach this high-risk age group. Future studies should explore potential common upstream or downstream mechanisms of CVD and cancer as well as public health strategies to cope with the double burden of disease.
© 2013 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  cancer; cardiovascular disease; multimorbidity; prevalence

Mesh:

Year:  2013        PMID: 24372982     DOI: 10.1111/joim.12165

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  10 in total

1.  Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort.

Authors:  Melanie R Keats; Yunsong Cui; Scott A Grandy; Louise Parker
Journal:  J Cancer Surviv       Date:  2016-11-16       Impact factor: 4.442

2.  Developing Faith-Based Health Promotion Programs that Target Cardiovascular Disease and Cancer Risk Factors.

Authors:  Clare Burchenal; Shanna Tucker; Orysya Soroka; Francesse Antoine; Rosio Ramos; Holly Anderson; Naa-Solo Tettey; Erica Phillips
Journal:  J Relig Health       Date:  2021-12-01

3.  Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction.

Authors:  Giovanni Cioffi; Ombretta Viapiana; Luigi Tarantini; Federica Ognibeni; Giovanni Orsolini; Angelo Fassio; Davide Gatti; Maurizio Rossini; Alessandro Giollo
Journal:  Intern Emerg Med       Date:  2020-03-27       Impact factor: 3.397

4.  Co-morditities of environmental diseases: A common cause.

Authors:  Harold I Zeliger
Journal:  Interdiscip Toxicol       Date:  2014-12-30

5.  Changes in Age Distribution of Obesity-Associated Cancers.

Authors:  Siran M Koroukian; Weichuan Dong; Nathan A Berger
Journal:  JAMA Netw Open       Date:  2019-08-02

6.  Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Noriaki Tabata; Baravan Al-Kassou; Atsushi Sugiura; Jasmin Shamekhi; Hendrik Treede; Masanobu Ishii; Kenichi Tsujita; Nikos Werner; Eberhard Grube; Georg Nickenig; Jan-Malte Sinning
Journal:  JACC CardioOncol       Date:  2019-12-17

7.  Neoplasms and the Evaluation of Risk of Cardiovascular Disease.

Authors:  Cristina Salvadori Bittar
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

8.  Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study.

Authors:  Mariusz Dąbrowski; Elektra Szymańska-Garbacz; Zofia Miszczyszyn; Tadeusz Dereziński; Leszek Czupryniak
Journal:  Oncotarget       Date:  2017-05-09

9.  Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer.

Authors:  Atul Batra; Dropen Sheka; Shiying Kong; Winson Y Cheung
Journal:  BMC Cancer       Date:  2020-10-15       Impact factor: 4.430

10.  Cancer and cardiovascular-related perceived risk in a diverse cancer center catchment area.

Authors:  Laura C Pinheiro; Orysya Soroka; Dominic Razon; Rosio Ramos; Francesse Antoine; Andrew J Dannenberg; Monika Safford; Stephen J Peterson; Rulla M Tamimi; David M Nanus; Erica Phillips
Journal:  Cancer Causes Control       Date:  2022-03-11       Impact factor: 2.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.